Inbiome

Private

AmsterdamHealthcare & Life Scienceshttps://inbiome.com/

Last Round

Series A

Apr 1, 2026

Total Funding Raised

$16M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Inbiome is a biotechnology company that has developed a patented Molecular Culture technology, which uses machine learning and chemistry for rapid bacterial diagnostics and microbiome analysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Defense Tech

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

molecular diagnosticsrapid diagnosticsbacterial infection diagnosticsPCR diagnosticsinfectious disease diagnosticsculture-independent diagnosticsmicrobiome analysisantimicrobial resistanceAMRprecision medicinemicrobiology servicesbattlefield diagnosticsdual-use technologybiothreat detectionIVDR certification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inbiome Comps

Public and private peers based on sector, stage, and business model.

Inbiome comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inbiome Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 1, 2026
Grant	Jan 11, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Dries Budding

CEO

Executive Team

Inbiome Investors

Notable investors and investment history

Inbiome investors
Investor	Rounds
European Innovation Council	Grant
Slingshot Ventures	Series A
NATO Innovation Fund	Series A
Voima Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 1, 2026
$16M round completed.
Jan 22, 2026
Monthly visitors grew 789% MoM, reaching 7.5K.

View all signals

Inbiome Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Inbiome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inbiome's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam

Employee Range27

Year Founded2019

Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.